Protective effect of hydroxychloroquine in systemic lupus erythematosus. Prospective long-term study of an Israeli cohort

scientific article published on January 2002

Protective effect of hydroxychloroquine in systemic lupus erythematosus. Prospective long-term study of an Israeli cohort is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1191/0961203302LU203RA
P698PubMed publication ID12139373

P50authorAbraham WeinbergerQ72962209
P2093author name stringY Molad
A J Wysenbeek
D Guedj
A Gorshtein
M Amit-Vazina
R Majadla
P2860cites workThe 1982 revised criteria for the classification of systemic lupus erythematosusQ29547225
Frequency of fractures in women with systemic lupus erythematosus: comparison with United States population dataQ30577177
A prospective study of survival and prognostic indicators of systemic lupus erythematosus in a southern Chinese populationQ33332503
Accelerated atheroma in lupus--backgroundQ33915419
Is there an association of malignancy with systemic lupus erythematosus? An analysis of 276 patients under long-term reviewQ34062606
Do present damage and health perception in patients with systemic lupus erythematosus predict extent of future damage?: a prospective study.Q35548947
Trabecular and cortical bone loss in systemic lupus erythematosusQ40949194
The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosusQ40974327
A long-term study of hydroxychloroquine withdrawal on exacerbations in systemic lupus erythematosus. The Canadian Hydroxychloroquine Study GroupQ41926859
A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosusQ41942545
Cholesterol-lowering effect of hydroxychloroquine in patients with rheumatic disease: reversal of deleterious effects of steroids on lipidsQ41943371
Vascular stiffness in women with systemic lupus erythematosusQ43576508
The bimodal mortality pattern of systemic lupus erythematosusQ43703475
Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.Q44441787
Malignancy in systemic lupus erythematosusQ44602256
Biochemical characterization of ADP-ribose polymer metabolism in SLE.Q51031046
Impact of disease activity and cumulative damage on the health of lupus patients.Q53580496
Non-Hodgkin's lymphoma and other cancers among a cohort of patients with systemic lupus erythematosusQ58006893
P433issue6
P921main subjectIsraelQ801
hydroxychloroquineQ421094
P304page(s)356-361
P577publication date2002-01-01
P1433published inLupusQ6704846
P1476titleProtective effect of hydroxychloroquine in systemic lupus erythematosus. Prospective long-term study of an Israeli cohort
P478volume11